Table 1 Reported cases of rectal leiomyosarcoma
Year | Author | Age (years) | Sex | Tumor size | Gross appearance | Mitotic count (/50HPF) | Recurrence | Outcome | Survival (months) |
|---|---|---|---|---|---|---|---|---|---|
2001 | Miettinen et al. | 63 | F | 2.0 | Intraluminal polyp | 68 | – | Alive | 191 |
32 | F | 2.3 | Intraluminal polyp | >100 | – | Alive | 39 | ||
79 | F | 2.5 | Intraluminal polyp | 26 | – | Death from OD | 55 | ||
67 | F | 3.0 | Plaque-like | >100 | Peritoneum | Death from OD | 61 | ||
52 | M | 3.0 | Intramural | 46 | – | Death from OD | 70 | ||
40 | M | 3.5 | Intraluminal polyp | 45 | – | Alive | 325 | ||
24 | F | 5.5 | Intraluminal polyp | 62 | – | NR | NR | ||
73 | F | NR | NR | >100 | – | Death from LMS | 24 | ||
2013 | Yamamoto et al. | 88 | F | 6.5 | Borrmann type 2-like | 38 | Skin, liver, peritoneum | Death from LMS | 24 |
2016 | Our case | 87 | M | 7.5 | Submucosal tumor | 15 | Lung | Death from LMS | 12 |